Skip to content
OpenCapital
Get started

Clearwater Analytics CWAN Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number at other companies

MSCI logo
MSCIMSCI
97K—

Other financials

Income statement

See full
Revenue$221.2M+74.4%
Gross profit$145.5M+56.6%
Operating income$9.0M+26.9%
Net income-$2.8M-143%
EPS (diluted)-$0.01-133%

Balance sheet

See full
Cash & equivalents$81.5M-71.2%
Total debt$860.8M+1,189%
Total equity$2.0B+83.7%
Total assets$3.0B+135%

Cash flow

See full
Operating cash flow$17.7M-27.9%
CapEx$6.4M+339%
Free cash flow$11.2M-51.2%

Valuation

See full
Market cap$7.22B+8.9%
Enterprise value$8B+25.4%
P/S8.8×-5.2×

Profitability

See full
Gross margin66%-7.0pp
Operating margin-0.7%-4.8pp
Net margin-5.9%-96.0pp
FCF margin18.5%—

Returns & leverage

See full
Return on equity-3.1%-59.4pp
Debt / equity0.4×+0.4×
Current ratio2.3×-2.8×

Where this comes from

Reported directly by Clearwater Analytics in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.

The official record: Clearwater Analytics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clearwater Analytics's share based compensation arrangement by share based payment award options exercisable number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clearwater Analytics's share based compensation arrangement by share based payment award options exercisable number?
Clearwater Analytics (CWAN) reported share based compensation arrangement by share based payment award options exercisable number of $7.21M in Q1 2026.
How has Clearwater Analytics's share based compensation arrangement by share based payment award options exercisable number changed year-over-year?
Clearwater Analytics's share based compensation arrangement by share based payment award options exercisable number decreased by 16.9% year-over-year, from $8.68M to $7.21M.